Identification of potentially irritating intravenous medications
AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62 intravenous drugs commonly used in emergency care, pH and osmolarity were measured. Subsequently, based on these values, the theoretical capac...
Saved in:
Published in | Enfermería Intensiva (English ed.) Vol. 33; no. 3; pp. 132 - 140 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2022
|
Online Access | Get full text |
Cover
Loading…
Abstract | AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62 intravenous drugs commonly used in emergency care, pH and osmolarity were measured. Subsequently, based on these values, the theoretical capacity to cause irritation or endovascular damage was determined and classified as high, moderate, and low. RESULTSSamples from 19 drugs for fluid therapy, 21 antibiotics and 22 drugs for intravenous use were studied. Glucose solutions, sodium bicarbonate 1M and mannitol 10% showed a high capacity to cause venous irritation. Vancomycin, ciprofloxacin, amiodarone, haloperidol, and labetalol solution presented a high capacity for irritation based on their acidic pH. The antibiotics, dexketoprofen, diazepam, digoxin, etomidate, phenytoin, levetiracetam and metamizole also showed high osmotic values in their reconstituted or undiluted presentations. Moreover, osmolarity of diazepam, digoxin and phenytoin remained high despite being diluted in 100 ml of saline. CONCLUSIONSKnowing the pH and osmolarity of intravenous drugs allows their capacity to cause endothelial damage to be assessed. The use of comprehensive tables based on the chemical properties of the drugs can be a useful tool to help prevent chemically-induced phlebitis. |
---|---|
AbstractList | AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62 intravenous drugs commonly used in emergency care, pH and osmolarity were measured. Subsequently, based on these values, the theoretical capacity to cause irritation or endovascular damage was determined and classified as high, moderate, and low. RESULTSSamples from 19 drugs for fluid therapy, 21 antibiotics and 22 drugs for intravenous use were studied. Glucose solutions, sodium bicarbonate 1M and mannitol 10% showed a high capacity to cause venous irritation. Vancomycin, ciprofloxacin, amiodarone, haloperidol, and labetalol solution presented a high capacity for irritation based on their acidic pH. The antibiotics, dexketoprofen, diazepam, digoxin, etomidate, phenytoin, levetiracetam and metamizole also showed high osmotic values in their reconstituted or undiluted presentations. Moreover, osmolarity of diazepam, digoxin and phenytoin remained high despite being diluted in 100 ml of saline. CONCLUSIONSKnowing the pH and osmolarity of intravenous drugs allows their capacity to cause endothelial damage to be assessed. The use of comprehensive tables based on the chemical properties of the drugs can be a useful tool to help prevent chemically-induced phlebitis. |
Author | Fernández-Aedo, I. Miguelez, C. Ballesteros-Peña, S. Tønnesen, J. Vallejo-De la Hoz, G. |
Author_xml | – sequence: 1 givenname: S. surname: Ballesteros-Peña fullname: Ballesteros-Peña, S. – sequence: 2 givenname: I. surname: Fernández-Aedo fullname: Fernández-Aedo, I. – sequence: 3 givenname: G. surname: Vallejo-De la Hoz fullname: Vallejo-De la Hoz, G. – sequence: 4 givenname: J. surname: Tønnesen fullname: Tønnesen, J. – sequence: 5 givenname: C. surname: Miguelez fullname: Miguelez, C. |
BookMark | eNpNkDFPwzAQhS1UJErpL2DJyJJwduzE3kAVlEqVWGC2XOeCXCV2sFOk_ntS2oHpTnfvnd59t2Tmg0dC7ikUFGj1uC_Qtw4LBowWIAqA8orMmWAqV5LD7F9_Q5Yp7QGACVXVrJ6Tp02DfnSts2Z0wWehzYYwnkam646Zi9GN08Z_Zc6P0fygD4eU9dhcDOmOXLemS7i81AX5fH35WL3l2_f1ZvW8zS2VlOc1RSWBGsPVTlHLQRljleWspcKYqpZCMZTSGmYbLBVFAVI0gu8a2XCxq8sFeTjfHWL4PmAade-Sxa4zHqdImtXT35RXik_S8iy1MaQUsdVDdL2JR01Bn5Dpvf5Dpk_INAg9WctfzjFjCg |
CitedBy_id | crossref_primary_10_3390_antibiotics12081338 crossref_primary_10_3389_fmed_2022_1037274 |
Cites_doi | 10.1007/s40268-020-00329-w 10.1097/NAN.0000000000000081 10.1177/1129729819877323 10.1086/674398 10.7764/Horiz_Enferm.22.2.37 10.1038/s41598-018-21617-1 10.1097/00000446-200302000-00027 10.2131/jts.24.113 10.2146/ajhp161028 10.4103/jfmpc.jfmpc_559_19 10.4037/ccn2019381 10.1097/00152193-199811000-00021 10.1111/jocn.14760 10.1590/0104-1169.0192.2603 10.7326/0003-4819-114-10-845 |
ContentType | Journal Article |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1016/j.enfie.2021.05.003 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2529-9840 |
EndPage | 140 |
ExternalDocumentID | 10_1016_j_enfie_2021_05_003 |
GroupedDBID | --M 0R~ AACTN AAEDT AAEDW AAKOC AALRI AAOAW AAXUO AAYXX ABMAC ACDAQ ACGFS ACRLP ADBBV AEBSH AFJKZ AFTJW AFXIZ AGUBO AIEXJ AIKHN AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AXJTR BNPGV CITATION EBS EFJIC EJD FDB FIRID KOM M41 O9- ROL SNG SSH SSZ T5K ~G- 7X8 |
ID | FETCH-LOGICAL-c1814-71e9801aa49b91c409aac9c42f15aa678592e88ca2cde391e5085d54bd8d45b73 |
ISSN | 2529-9840 |
IngestDate | Sat Aug 17 02:21:29 EDT 2024 Thu Sep 26 16:31:59 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1814-71e9801aa49b91c409aac9c42f15aa678592e88ca2cde391e5085d54bd8d45b73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2700314694 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2700314694 crossref_primary_10_1016_j_enfie_2021_05_003 |
PublicationCentury | 2000 |
PublicationDate | 2022-07-00 20220701 |
PublicationDateYYYYMMDD | 2022-07-01 |
PublicationDate_xml | – month: 07 year: 2022 text: 2022-07-00 |
PublicationDecade | 2020 |
PublicationTitle | Enfermería Intensiva (English ed.) |
PublicationYear | 2022 |
References | Garate (10.1016/j.enfie.2021.05.003_bib0060) 2015 Manrique-Rodríguez (10.1016/j.enfie.2021.05.003_bib0045) 2021; 21 Plan Nacional de Resistencia a Antibióticos (10.1016/j.enfie.2021.05.003_bib0055) 2019 Aizpuru Martínez (10.1016/j.enfie.2021.05.003_bib0035) 2021 Gorski (10.1016/j.enfie.2021.05.003_bib0085) 2015; 38 Stranz (10.1016/j.enfie.2021.05.003_bib0095) 2005 Maklin (10.1016/j.enfie.2021.05.003_bib0120) 2003; 103 10.1016/j.enfie.2021.05.003_bib0115 Mandal (10.1016/j.enfie.2021.05.003_bib0020) 2019; 8 Maki (10.1016/j.enfie.2021.05.003_bib0105) 1991; 114 Wallis (10.1016/j.enfie.2021.05.003_bib0010) 2014; 35 Nicotera (10.1016/j.enfie.2021.05.003_bib0065) 2011; 30 Oragano (10.1016/j.enfie.2021.05.003_bib0070) 2019; 39 Lv (10.1016/j.enfie.2021.05.003_bib0005) 2020; 21 Simin (10.1016/j.enfie.2021.05.003_bib0015) 2019; 28 Pérez Melgarejo (10.1016/j.enfie.2021.05.003_bib0050) 2011; 22 Piper (10.1016/j.enfie.2021.05.003_bib0110) 2018; 8 Registered Nurses Association of Ontario (10.1016/j.enfie.2021.05.003_bib0025) 2004 Stranz (10.1016/j.enfie.2021.05.003_bib0100) 2002; 6 Meng (10.1016/j.enfie.2021.05.003_bib0080) 2018; 75 Kokotis (10.1016/j.enfie.2021.05.003_bib0040) 1998; 28 Milutinović (10.1016/j.enfie.2021.05.003_bib0030) 2015; 23 Bruniera (10.1016/j.enfie.2021.05.003_bib0075) 2015; 19 Kuwahara (10.1016/j.enfie.2021.05.003_bib0090) 1999; 24 |
References_xml | – year: 2004 ident: 10.1016/j.enfie.2021.05.003_bib0025 contributor: fullname: Registered Nurses Association of Ontario – volume: 30 start-page: 34 year: 2011 ident: 10.1016/j.enfie.2021.05.003_bib0065 article-title: La flebite associata alla terapia endovenosa/infusionale [Phlebitis associated to intravenous/infusional therapy] publication-title: Assist Inferm Ric contributor: fullname: Nicotera – volume: 21 start-page: 39 year: 2021 ident: 10.1016/j.enfie.2021.05.003_bib0045 article-title: Standardization and chemical characterization of intravenous therapy in adult patients: a step further in medication safety publication-title: Drugs R D doi: 10.1007/s40268-020-00329-w contributor: fullname: Manrique-Rodríguez – volume: 38 start-page: 27 year: 2015 ident: 10.1016/j.enfie.2021.05.003_bib0085 article-title: Intermittently delivered IV medication and pH: reevaluating the evidence publication-title: J Infus Nurs doi: 10.1097/NAN.0000000000000081 contributor: fullname: Gorski – volume: 21 start-page: 342 year: 2020 ident: 10.1016/j.enfie.2021.05.003_bib0005 article-title: The incidence and risk of infusion phlebitis with peripheral intravenous catheters: a meta-analysis publication-title: J Vasc Access doi: 10.1177/1129729819877323 contributor: fullname: Lv – volume: 35 start-page: 63 year: 2014 ident: 10.1016/j.enfie.2021.05.003_bib0010 article-title: Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial publication-title: Infect Control Hosp Epidemiol doi: 10.1086/674398 contributor: fullname: Wallis – volume: 22 start-page: 37 year: 2011 ident: 10.1016/j.enfie.2021.05.003_bib0050 article-title: Flebitis postinfusión en catéteres venosos periféricos: una actualización del arte publication-title: Horiz Enferm doi: 10.7764/Horiz_Enferm.22.2.37 contributor: fullname: Pérez Melgarejo – volume: 8 start-page: 3441 year: 2018 ident: 10.1016/j.enfie.2021.05.003_bib0110 article-title: The mechanistic causes of peripheral intravenous catheter failure based on a parametric computational study publication-title: Sci Rep doi: 10.1038/s41598-018-21617-1 contributor: fullname: Piper – year: 2015 ident: 10.1016/j.enfie.2021.05.003_bib0060 contributor: fullname: Garate – volume: 103 start-page: 55 year: 2003 ident: 10.1016/j.enfie.2021.05.003_bib0120 article-title: Phlebitis publication-title: Am J Nurs doi: 10.1097/00000446-200302000-00027 contributor: fullname: Maklin – volume: 24 start-page: 113 year: 1999 ident: 10.1016/j.enfie.2021.05.003_bib0090 article-title: Experimental infusion phlebitis: tolerance pH of peripheral veins publication-title: J Toxicol Sci doi: 10.2131/jts.24.113 contributor: fullname: Kuwahara – volume: 75 start-page: 284 year: 2018 ident: 10.1016/j.enfie.2021.05.003_bib0080 article-title: Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp161028 contributor: fullname: Meng – ident: 10.1016/j.enfie.2021.05.003_bib0115 – volume: 8 start-page: 2827 year: 2019 ident: 10.1016/j.enfie.2021.05.003_bib0020 article-title: Study on incidence of phlebitis following the use of pherpheral intravenous catheter publication-title: J Family Med Prim Care doi: 10.4103/jfmpc.jfmpc_559_19 contributor: fullname: Mandal – year: 2021 ident: 10.1016/j.enfie.2021.05.003_bib0035 contributor: fullname: Aizpuru Martínez – start-page: 1 year: 2005 ident: 10.1016/j.enfie.2021.05.003_bib0095 article-title: The implications of osmolality, osmolarity and pH in infusion therapy publication-title: INS Annual Conference contributor: fullname: Stranz – volume: 39 start-page: e1 year: 2019 ident: 10.1016/j.enfie.2021.05.003_bib0070 article-title: Phlebitis in intravenous amiodarone administration: incidence and contributing factors publication-title: Crit Care Nurse doi: 10.4037/ccn2019381 contributor: fullname: Oragano – volume: 28 start-page: 41 year: 1998 ident: 10.1016/j.enfie.2021.05.003_bib0040 article-title: Preventing chemical phlebitis publication-title: Nursing doi: 10.1097/00152193-199811000-00021 contributor: fullname: Kokotis – year: 2019 ident: 10.1016/j.enfie.2021.05.003_bib0055 contributor: fullname: Plan Nacional de Resistencia a Antibióticos – volume: 28 start-page: 1585 year: 2019 ident: 10.1016/j.enfie.2021.05.003_bib0015 article-title: Incidence, severity and risk factors of peripheral intravenous cannula-induced complications: an observational prospective study publication-title: J Clin Nurs doi: 10.1111/jocn.14760 contributor: fullname: Simin – volume: 23 start-page: 677 year: 2015 ident: 10.1016/j.enfie.2021.05.003_bib0030 article-title: Fatores de risco para flebite: estudo com questionário sobre a percepção dos enfermeiros publication-title: Rev Lat Am doi: 10.1590/0104-1169.0192.2603 contributor: fullname: Milutinović – volume: 19 start-page: 694 year: 2015 ident: 10.1016/j.enfie.2021.05.003_bib0075 article-title: The use of vancomycin with its therapeutic and adverse effects: a review publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Bruniera – volume: 114 start-page: 845 year: 1991 ident: 10.1016/j.enfie.2021.05.003_bib0105 article-title: Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-114-10-845 contributor: fullname: Maki – volume: 6 start-page: 216 year: 2002 ident: 10.1016/j.enfie.2021.05.003_bib0100 article-title: A review of pH and Osmolarity publication-title: Int J Pharm Compd contributor: fullname: Stranz |
SSID | ssj0002596727 |
Score | 2.235149 |
Snippet | AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 132 |
Title | Identification of potentially irritating intravenous medications |
URI | https://search.proquest.com/docview/2700314694 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZWrYS4oPISbWkVJG4hUeLYu_GNLS1sQa2Q2KLeIjuZSF0tCVrSA_wifmbHj2S9tEKUSxR5k9EmMxl__uZhQl7nCSDuAIikkipi1UREeV6iM-T5BFcPshqbKv6z8_Hsgn285Jej0W8va-m6U3H56866kv_RKo6hXnWV7D00OwjFATxH_eIRNYzHf9KxrbKtHe1mkpfbTg_J5fJneLVamQbcpmil09sMmXasJpru8XQ9La8r_765yPmxDPvcdqkxqCv2DaGKPergSO_DohsttD-iz6BvPEoNFv0S-zS1kZhqrjqaQmWo2dPhgq9axqKNjiFcynDWGj77w_Dz3EjNG71Ppq0iiX2egq5zWp07o5yKSOS2OVMMd4w5f2wbYzi7yzznmjom1M7Tqb3r1hRg2YhFDE19pfug0tS0Zk2y9YzXR_n_mAiH9MQ-821RGCGFFlIkvDBtZbcpujT0pdvT00-z84HPw2WkDmrrvQz7h-qbXJl0wlt_ZxMIbeIAA27mO-SRW5UEU2tij8kImifkwZnLu3hK3m5aWtDWgWdpwdrSAs_SAs_SnpGL9yfzd7PI7b0RlYj5dIouCAQvUjKhRFqyREhZipLROuVSIsLhggJ-1ZKWFWQiBQT6vOJMVXnFuJpkz8lW0zbwggT1BAAoXs2VZEqOFa3qPGE1ZIqqTGW75E3_IorvtsVK8RcN7JJX_csq0BXq-JZsAJ-q0DkUGc78gu3dT-Q-ebi22Jdkq1tdwwFizU4dOjXfAOjOfCA |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+potentially+irritating+intravenous+medications&rft.jtitle=Enfermer%C3%ADa+Intensiva+%28English+ed.%29&rft.au=Ballesteros-Pe%C3%B1a%2C+S.&rft.au=Fern%C3%A1ndez-Aedo%2C+I.&rft.au=Vallejo-De+la+Hoz%2C+G.&rft.au=T%C3%B8nnesen%2C+J.&rft.date=2022-07-01&rft.issn=2529-9840&rft.eissn=2529-9840&rft.volume=33&rft.issue=3&rft.spage=132&rft.epage=140&rft_id=info:doi/10.1016%2Fj.enfie.2021.05.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_enfie_2021_05_003 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2529-9840&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2529-9840&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2529-9840&client=summon |